Krystal Biotech, Inc. (BIT:1KRYS)

Italy · Delayed Price · Currency is EUR

119.30

-4.30 (-3.48%)

At close: Jun 12, 2025

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Genetic Medicines	290.52M	Log In
Genetic Medicines Growth	473.02%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
United States	290.52M	Log In
United States Growth	473.02%	Log In